CTMX vs XLU
CytomX Therapeutics Inc (CTMX) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
XLU (XLU) common stock.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
XLU does not have a complete income-statement cache yet.
CTMX currently screens at market cap $653.1M. XLU currently screens at market cap $0.
Not investment advice. Open the CTMX and XLU stock pages for the full models.
Not investment advice.